Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis

Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis

(2015) Warwick J Locke et al.   Clinical Epigenetics

BRCA1 as Target for Breast Cancer Prevention and Therapy

(2014) Alberto Romagnolo et al.   Anti-Cancer Agents in Medicinal Chemistry

Nuclear Receptors and Epigenetic Regulation: Opportunities for Nutritional Targeting and Disease Prevention

(2014) Donato F. Romagnolo et al.   Advances in Nutrition

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer

(2013) William Jacot et al.   BMC CANCER

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

(2013) E H Lips et al.   BRITISH JOURNAL OF CANCER

Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: Preventive effects of resveratrol

(2013) Andreas J. Papoutsis et al.   MOLECULAR CARCINOGENESIS

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression

(2012) Amanjit Bal et al.   VIRCHOWS ARCHIV

BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 Cells

(2011) Andreas J. Papoutsis et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Ribavirin restores ESR1 Gene Expression and Tamoxifen Sensitivity in ESR1 negative Breast Cancer Cell Lines

(2011) Anne Sappok et al.   Clinical Epigenetics

Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer

(2010) E. M. Wong et al.   Cancer Prevention Research

Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors

(2010) Teresa Tapia et al.   Epigenetics

Resveratrol Prevents Epigenetic Silencing of BRCA-1 by the Aromatic Hydrocarbon Receptor in Human Breast Cancer Cells

(2010) Andreas J. Papoutsis et al.   JOURNAL OF NUTRITION

Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity

(2009) Parviz Ghadirian et al.   BREAST CANCER RESEARCH AND TREATMENT

Vitamin C and  -naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats

(2009) S. M. Mense et al.   CARCINOGENESIS

The Complex Relationship between BRCA1 and ER  in Hereditary Breast Cancer

(2009) J. J. Gorski et al.   CLINICAL CANCER RESEARCH

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

(2009) M. A. Barhoover et al.   MOLECULAR PHARMACOLOGY

Constitutive regulation ofCYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue

(2007) Xinhai Yang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY